Revance specializes in a neuromodulator therapeutics pipeline featuring DaxibotulinumtoxinA for Injection, utilizing acetylcholine release inhibition and neuromuscular blocking agents to temporarily improve moderate to severe glabellar lines in adults. The product uses peptide-powered technology to provide long-lasting treatment for frown lines.